Background: Colorectal cancer (CRC) is a major cause of morbidity and mortality in France.
Only scanty data on cost-effectiveness of CRC screening in Europe are available …

Background: A nationwide colorectal cancer (CRC) screening program was set up in France
from 2009 for average-risk, asymptomatic people aged 50–74 years based on an …

Introduction Colorectal cancer (CRC) is the second leading cause of death worldwide and
the use of CRC screening tests can reduce the incidence and mortality of the disease by …

As long as Medicare and insurance companies pay for screening colonoscopies in covered
patients, incentives will exist for GI societies to continue to promote colonoscopy as the …

AIM: To provide an update on colorectal cancer (CRC) screening programmes in non-
European Union (EU)-28 Council of Europe member states as of December 2015 …

To appreciate what it means to say that colorectal cancer (CRC) screening is costeffective,
or that a given CRC screening strategy is more cost-effective than another one, it is valuable …

Comparability of cost‐effectiveness of colorectal cancer (CRC) screening strategies is
limited if heterogeneous study data are combined. We analyzed prospective empirical data …

Unlike other types of cancer, there are several options for screening for colorectal cancer
(CRC). The most extensively examined method, faecal occult blood testing (FOBT), has …

Background Colorectal cancer (CRC) is one of the leading causes of cancer mortality in
Belgium. In Flanders (Belgium), a population-based screening program with a biennial …

Aim The aim was to use newly available data to estimate the cost effectiveness and
endoscopy requirements of screening options for colorectal cancer (CRC) to inform …